NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ORIC Pharmaceuticals, Inc. ("Oric" or the "Company") (NASDAQ: ORIC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Hence then, the article about investor alert pomerantz law firm investigates claims on behalf of investors of oric pharmaceuticals inc oric was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC )
Also on site :
- My Kid Is Now Banned From All Family Functions Until Further Notice. He Doesn’t Deserve This!
- JPMorgan exec accused of making subordinate her ‘office sex slave’ – The Sun
- Stephen Lang, Sam Worthington & Luke Bracey To Star In 1950s Crime-Thriller ‘Eyes Along The Valley’ — Cannes Market